May 12 (Reuters) - ProMIS Neurosciences Inc PMN.TO :
* PROMIS NEUROSCIENCES IDENTIFIES MULTIPLE NOVEL TARGETS ON SARS COV-2 FOR DEVELOPMENT OF A HIGHLY ACCURATE COVID-19 ANTIBODY TEST
* PROMIS NEUROSCIENCES INC - PROMIS HAS IDENTIFIED 18 POTENTIAL ANTIBODY TARGETS UNIQUE TO SPIKE PROTEIN HALO OF SARS COV-2